Female Stress Urinary Incontinence Treatment Devices Market Research Reports 2020 Key Players are Johnson & Johnson, Bard Medical, American Medical Solutions

The rising prevalence of urinary incontinence in pregnant women, stress urinary incontinence due to diabetes, gynaecology disorders, and urinary incontinence in postmenopausal women are some of the major factors propelling the growth of the female stress urinary incontinence treatment devices market. Several other risk factors that increase the risk of developing stress urinary incontinence in women include high body weight, type of childbirth, age, pelvic surgery, etc.

The Report titled "Female Stress Urinary Incontinence Treatment Devices Market" has recently added by MarketInsightsReports to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts.

Available 30% Discount Till Limited Period

Get a Free Sample Copy of the Report:
https://www.marketinsightsreports.com/reports/04131991499/global-female-stress-urinary-incontinence-treatment-devices-market-research-report-2020/inquiry?Mode=88

Top Companies operating in the Global Female Stress Urinary Incontinence Treatment Devices market profiled in the report are: Johnson & Johnson, Bard Medical, American Medical Solutions, Boston ScientificTeleflex, Karl Storz and Coloplast.

The female stress urinary incontinence treatment devices market is expected to grow at a CAGR of 7% over 2019-2029.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Global Industry news:
[19 feb,2020]Innovo, a Wearable Device for Stress Urinary Incontinence, Now Available OTC- A wearable device to treat stress urinary incontinence, Innovo®, has been granted over-the-counter clearance by the Food and Drug Administration. Innovo is a transcutaneous muscle electrical stimulator that targets weakened pelvic floor muscles. The device, which was previously only available with a prescription, is used for 30 minutes a day, 5 days a week for 3 months, after which users can follow a maintenance routine of one to two 30 minute sessions per week.

"In the privacy of their own home, women can simply pull on a pair of shorts for a 30-minute Innovo® pelvic floor workout," said Ruth M. Maher, PhD, DPT, co-inventor of Innovo and Professor, Department of Physical Therapy, Philadelphia College of Osteopathic Medicine (PCOM) Georgia. "By strengthening and re-educating their pelvic floor muscles, they have the opportunity to live a leak-free life in as little as 3 months."

A randomized controlled trial comparing Innovo with an FDA-approved intravaginal device found that the neuromuscular external electrical stimulation device was associated with significant improvement in stress urinary incontinence measures. However, it was not found to be noninferior to the intravaginal device.

AUA and SUFU Release New Clinical Guideline on the Treatment of Stress Urinary Incontinence[April 18, 2017 ]- With nearly 50 percent of women in the United States experiencing symptoms of stress urinary incontinence (SUI), the American Urological Association (AUA), a leading global urology association and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU), the premier urological subspecialty society dedicated to improving the art and science of female pelvic medicine and reconstructive surgery, recently released a joint evidence-based clinical guideline on the surgical treatment of SUI in women.

SUI is defined as the involuntary leakage of urine due to increased abdominal pressure, which can be caused by such activities as physical exercise, sneezing, laughing or coughing. Approximately half of all women experience SUI symptoms during their lifetime, and many of these women are sufficiently bothered by their symptoms to seek treatment from a physician. Pelvic floor muscle exercises and other nonsurgical treatments can be effective therapies, but many women choose to undergo surgery to treat their SUI symptoms.

The joint clinical guideline for the surgical treatment of SUI makes 24 recommendations in total. Determining when to perform additional evaluations to confirm and characterize SUI; discussing risks, benefits and alternatives to various surgical treatment options such as midurethral synthetic sling procedures; and suggesting surgical treatment of SUI be deferred until after child bearing is complete, are among the recommendations made.

Global Female Stress Urinary Incontinence Treatment Devices Market Split by Product Type and Applications:
Market Segment by Type, covers:

Non-surgical Treatment
Surgical Treatment

Market Segment by Applications, covers:
Gynecology Clinic
Hospitals
Ambulatory Surgical Centers

Regional Analysis For Female Stress Urinary Incontinence Treatment Devices Market:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Inquire For Discount:
https://www.marketinsightsreports.com/reports/04131991499/global-female-stress-urinary-incontinence-treatment-devices-market-research-report-2020/discount?Mode=88

Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation.

Influence of the Female Stress Urinary Incontinence Treatment Devices Market Report:
-Comprehensive assessment of all opportunities and risk in the Female Stress Urinary Incontinence Treatment Devices market.
-Female Stress Urinary Incontinence Treatment Devices market recent innovations and major events.
-Detailed study of business strategies for growth of the Female Stress Urinary Incontinence Treatment Devices market-leading players.
-Conclusive study about the growth plot of Female Stress Urinary Incontinence Treatment Devices market for forthcoming years.
-In-depth understanding of Female Stress Urinary Incontinence Treatment Devices market-particular drivers, constraints and major micro markets.
-Favourable impression inside vital technological and market latest trends striking the Female Stress Urinary Incontinence Treatment Devices market.

To Buy Report :
https://www.marketinsightsreports.com/report/purchase/04131991499?mode=su&mode=88

Note- All the reports that we list have been tracking the impact of COVID-19 the market. Both upstream and downstream of the entire supplychain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

Irfan Tamboli (Head of Sales) - Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations

This release was published on openPR.